Pharma IQ: Trial Master Files and Inspection Readiness Improving Clinical Trial Documentation

Monday, July 10, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, July 10, 2017 /PRNewswire/ --

Europe's fastest growing, most interactive

and case-study led TMF & Inspection Readiness Conference brings together global clinical documentation and data management professionals. Delegates will come together to discuss strategies to perfect TMF, ensure products are able to launch faster
and improve interoperability.

The conference will take place in Amsterdam on the 25th - 28th September 2017. Early registration is rewarded so visit the event website for the latest early bird rates or email [email protected] to find out more.

As one of the most heavily regulated industries in the world, the success of clinical research relies heavily on accurate documentation and data management. Collating and maintaining well organised, accurate documentation that is easy to access and inspect is harder than it sounds. Moreover, inaccurate clinical data and critical findings have significant budgetary implications, adding extra pressure on clinical operations teams and TMF owners! Pharma IQ's TMF & Inspection Readiness conference is designed to help ease this pressure. Download the event programme here

About Pharma IQ  

Pharma IQ has 100k+ members and is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. Pharma IQ is dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community. To learn more visit trialmasterfile.iqpc.co.uk, or call us at +44(0)207-036-1300

Media Contact: Rumina Akther, Trainee Marketing Manager, IQPC: [email protected]  or call +44(0)207-036-1300

Press are invited to attend this important industry summit, if you would like to a complimentary press pass please email Rumina Akther on [email protected]

SOURCE Pharma IQ



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store